[1]
“IMPACT OF PHARMACEUTICAL INTERVENTION IN THE MANAGEMENT OF PATIENTS WITH GESTATIONAL DIABETES MELLITUS”, REMUNOM, vol. 12, no. 1, Nov. 2024, doi: 10.61164/rmnm.v12i1.3131.